Clinical trial
A Double-Blind, Placebo-Controlled, Single-Dose Evaluation of the Dexmedetomidine Transdermal System for Post-Operative Analgesia Following Bunionectomy
NCT02953054 is registered in ClinicalTrials.gov with Teikoku Pharma USA, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled, Single-Dose Evaluation of the Dexmedetomidine Transdermal System for Post-Operative Analgesia Following Bunionectomy
- Lead sponsor
- Teikoku Pharma USA, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 22, 2017
- Completion date
- July 3, 2017
- Enrollment
- 88 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
pain, postoperative